Neurology
1 drug is in development for Chronic Migraine.
- Companies
- 1
- Clinical trials
- 11
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Chronic Migraine pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| Atogepant | AbbVie Inc. (ABBV) |
About this indication
Chronic Migraine context
Neurology·MeSH: Migraine Disorders (D008881)
Narrower concept of MeSH descriptor Migraine
Prevalence
15000.0 / 100K
Incidence
1500.0 / 100K/yr
Frequently asked questions
How many drugs are in development for Chronic Migraine?
BioSniper tracks 1 drug in development for Chronic Migraine across 1 company.
How many clinical trials target Chronic Migraine?
There are 11 clinical trials targeting Chronic Migraine tracked by BioSniper.
What is the prevalence of Chronic Migraine?
The estimated prevalence of Chronic Migraine is approximately 15000.0 per 100,000 population.